As the minuscule quantities of endogenous BDNF in the brain have hampered the delineation of its physiopathology as well as a clear understanding of its cell biology, quantitative aspects are also discussed, including post-mortem measurements of BDNF levels in Alzheimer’s disease. The gene discussed is BDNF; the disease is early-onset autosomal dominant Alzheimer disease.